Ned Milenkovich Sheds Lights on HR 841 and the FDA’s Stance on CBD

In this installment of The Legal Prescription with Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, continues to shed light on HR 841 "The Hemp Bill." Ned discusses how the FDA's stance on CBD has affected small businesses and consumers, talks about the current marketplace, and highlights the benefits that pharmacists’ involvement could bring.